Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: BG Medicine, Danaher, Provista

Premium

BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week. He replaces Eric Bouvier, who will remain with the company as a consultant.

Sohmer previously was CEO of several medical device and diagnostics companies, including Pathway Diagnostics, Viracor-IBT Laboratories, and Orthocon, and he was chairman, president, and CEO of TriPath Imaging before it was acquired by Becton Dickinson.

Early in his career, Sohmer also was CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.


Danaher has re-elected seven directors to continue serving on the board until their terms expire in 2014, including Steven Rales, Donald Ehrlich, Linda Hefner Filler, Teri List-Stoll, Walter Lohr, John Schwieters, and Alan Spoon.


Provista Diagnsotics' stockholders have re-elected the members of its board of directors, including Anne Busquet, Jeffrey Gilman, Robert Hariri, Jack Levine, John Macaskill, David Reese, and John Zicarelli.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.